Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in Indiana 2026: $69 a month, plus yearly membership

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to Indiana from four of our partner programs. The lowest of the programs we track is $69 a month at Collective, plus a yearly membership, read on November 11, 2026.

Medicaid for weight loss
Not covered
Partner programs that ship here
Eden, Collective, SnagRx and CoreAge Rx
Adults with obesity
37.5% (CDC, 2025)

Compounded tirzepatide prices in Indiana

ProgramMonthly priceCheckedProgram's site
Eden logoEden$129 a monthNovember 11, 2026Check price →
Collective logoCollective$69 a month, plus yearly membershipNovember 11, 2026Check price →
SnagRx logoSnagRx$149 a month, or $119 a month paid 12 months up frontNovember 11, 2026
CoreAge Rx logoCoreAge Rx$129 a monthNovember 11, 2026

Eden, Collective, SnagRx and CoreAge Rx pay GLP Chart when you buy through our links.

What a year of compounded tirzepatide costs in Indiana

  • Eden ships to Indiana at $1,548 for 12 months.
  • Collective ships to Indiana at $1,027 for 12 months with its membership.
  • SnagRx ships to Indiana at $1,788 for 12 months, or $1,428 if Indiana buyers pay 12 months up front.
  • CoreAge Rx ships to Indiana at $1,548 for 12 months.

For compounded semaglutide, Indiana buyers pay from $59 a month at Collective, plus a yearly membership, against $69 for compounded tirzepatide in Indiana.

Does The Healthy Indiana Plan (HIP) cover Zepbound?

The Healthy Indiana Plan (HIP) does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. Indiana Medicaid plans include Anthem Blue Cross and Blue Shield, CareSource Indiana, MDwise and Managed Health Services (Centene). No Indiana Medicaid plan pays for compounded tirzepatide, so it is a cash purchase. Indiana Medicaid GLP-1 rules.

Obesity in Indiana

37.5% of adults in Indiana had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. That puts Indiana 4.0 points above the national rate, about 4 in 10 Indiana adults.

More for Indiana

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.